Viraferonpeg Redi 80mcg Injection

उत्पाद अवलोकन

About Viraferonpeg Redi 80mcg Injection

Viraferonpeg Redi 80mcg Injection is a pegylated interferon alfa‑2b medication administered by subcutaneous injection. It is supplied as a ready‑to‑use prefilled syringe containing 80 micrograms of active ingredient. The product is indicated for the treatment of chronic hepatitis C infection in combination therapy and for certain cases of chronic hepatitis B infection. It is also used as monotherapy in selected patients with melanoma and other malignancies.

Key Benefits & Uses

• Treatment of chronic hepatitis C infection when administered with ribavirin
• Maintenance of sustained virologic response in selected patients
• Management of selected cases of chronic hepatitis B infection

Active Ingredient & Action

Pegylated interferon alfa‑2b works by binding to interferon receptors on target cells, activating antiviral genes and modulating immune responses. The pegylation extends circulation time, allowing less frequent dosing and sustained therapeutic effect.

Important Notes

Administration must be performed under medical supervision and dosage may be adjusted based on patient response and tolerability. The medication is not recommended for use during pregnancy unless the potential benefit justifies the risk, and proper storage requires refrigeration between 2°C and 8°C.